Picture of Valbiotis SA logo

ALVAL — Valbiotis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Valbiotis: Implementation Of Totum 63 At Laval University In Quebec City

June 28 (Reuters) - Valbiotis SA  ALVAL.PA :
    * VALBIOTIS ANNOUNCES THE IMPLEMENTATION OF THE TOTUM•63
MODE OF
ACTION CLINICAL STUDY BY INAF1 AT LAVAL UNIVERSITY IN QUEBEC
CITY, IN PARTNERSHIP WITH NESTLÉ HEALTH SCIENCE
    * STUDY WILL EXPLORE MODE OF ACTION OF TOTUM•63 IN HUMANS
    * ITS LAUNCH IS SCHEDULED FOR 4TH QUARTER OF 2021 IN CANADA

Source text for Eikon:  ID:nBw6sHrJa 
Further company coverage:  ALVAL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Valbiotis SA

See all news